Anders D. Hove, Director, 10% Owner at Anacor Pharmaceuticals, Inc. (ANAC), sold 150,000 shares at $14.06 ($2.1M) on 2013-11-15, disclosed to the SEC on 2013-11-19.
Open-market sale of $2.1M ANAC by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ANAC | SELL | 2015-12-17 | $100.1M | — | Filing → |
| ANAC | SELL | 2015-12-15 | $4.7M | — | Filing → |
| ANAC | SELL | 2015-11-12 | $10.4M | — | Filing → |